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Table 1 Rates (%) of morbidity/mortality for respondents and
non-respondents in Christensen et al. [1].
Response classiﬁcation
Outcome (%) Respondents
Non-
respondents
All groups
combined
All-cause mortality 11.25 16.69 12.75
Alcohol-related mortality 0.36 0.67 0.45
Alcohol-related morbidity 2.04 3.10 2.33
Smoking-related mortality 1.49 1.81 1.57
Smoking-related morbidity 3.59 4.33 3.79
Drug-related mortality 0.10 0.20 0.10
Drug-related morbidity 0.98 1.57 1.14
RESPONSE TO FERGUSSON & BODEN (2015):
THE IMPORTANCE OF CONSIDERING THE
IMPACTS OF SURVEY NON-PARTICIPATION
We thank Fergusson & Boden for their interest in our pa-
per, as detailed in their commentary [1]. They point to
some interesting issues which, for the main part, have also
been debated during the preparation of the paper.
The ﬁrst issue raised is that with the large sample size,
the likelihood of ﬁnding signiﬁcant group differences is
high. We acknowledge that this should be considered, but
as the hazard ratios in the present study are relatively large
and conﬁdence limits in most cases relatively narrow, we
consider the large sample size to be more a strength than
a drawback.
Ferguson & Boden also point to the fact that the low
baseline rates of morbidity and mortality will generate
relatively large hazard ratios, even with relatively small dif-
ferences in the absolute number of events between respon-
dents and non-respondents. We acknowledge that looking
only at relative differences can be somewhat misleading,
and we have therefore also provided the absolute number
of events and the rates for each group in our paper [2].
The most careful way of interpreting results is often to look
at both relative and absolute differences. However, as
pointed out by Ferguson & Boden, the use of respondent-
only data can cause biased estimates even when the abso-
lute difference in the number of events among respondents
and non-respondents is small.
It is suggested that the future sample sizes could be
reduced and the saved cost should be used on contacting
the non-contacts. This is an interesting reﬂection. Consid-
eration of strategies to raise the response rate among
speciﬁc groups of non-respondents is indeed warranted,
and different strategies to improve response rate among
different types on non-response groups are presented in
our paper [2]. However, the present study used pooled
data from two health surveys. Hence, the sample size
in each of the surveys is not as large as it might appear
in the commentary by Fergusson & Boden. Furthermore,
both surveys are designed to provide county and regional
representative data, respectively, and hence a minimum
sample size is required in each county/region. The
number of non-contacts is very small in the present
study, thanks to a notable effort to establish contact with
all invited individuals, and we think that it would be
very difﬁcult to establish contact with all invited indi-
viduals even if the resources are used differently. How-
ever, their suggestion will be considered when planning
future surveys.
Lastly, Ferguson & Boden argue that non-response
bias may have less of an impact when examining
exposure–outcome associations compared to studies of
prevalence estimates. This is often true [3–5]. There are,
however, exceptions, and thus the impact of non-response
bias in studies of associations cannot be assumed to be
negligible [6].
In summary, Ferguson & Boden raise some interesting
issues, which we agree need to be taken into accountwhen
both analysing and interpreting results on non-response in
surveys, while the impact of survey non-participation
should not be overlooked.
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